chr12-132618901-G-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_170682.4(P2RX2):c.85G>T(p.Glu29*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,362,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_170682.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000601 AC: 9AN: 149852Hom.: 0 Cov.: 29
GnomAD4 exome AF: 0.00000412 AC: 5AN: 1212368Hom.: 0 Cov.: 31 AF XY: 0.00000168 AC XY: 1AN XY: 593760
GnomAD4 genome AF: 0.0000601 AC: 9AN: 149852Hom.: 0 Cov.: 29 AF XY: 0.0000684 AC XY: 5AN XY: 73110
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change creates a premature translational stop signal (p.Glu29*) in the P2RX2 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in P2RX2 cause disease. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with P2RX2-related conditions. ClinVar contains an entry for this variant (Variation ID: 2045565). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at